![Mechanisms, diagnosis and management of hepatic encephalopathy | Nature Reviews Gastroenterology & Hepatology Mechanisms, diagnosis and management of hepatic encephalopathy | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrgastro.2010.116/MediaObjects/41575_2010_Article_BFnrgastro2010116_Fig1_HTML.jpg)
Mechanisms, diagnosis and management of hepatic encephalopathy | Nature Reviews Gastroenterology & Hepatology
![TIPS-related Hepatic Encephalopathy: Management Options with Novel Endovascular Techniques | RadioGraphics TIPS-related Hepatic Encephalopathy: Management Options with Novel Endovascular Techniques | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.241035028/asset/images/medium/g04ja22c1x.jpeg)
TIPS-related Hepatic Encephalopathy: Management Options with Novel Endovascular Techniques | RadioGraphics
![PDF) Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence PDF) Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence](https://www.researchgate.net/publication/329008709/figure/fig1/AS:737985024770048@1552960749508/Summary-of-numbers-of-journal-articles-indexed-on-PubMed-identified-using-the-search_Q320.jpg)
PDF) Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence
![IJMS | Free Full-Text | Molecular Mechanism Contributing to Malnutrition and Sarcopenia in Patients with Liver Cirrhosis | HTML IJMS | Free Full-Text | Molecular Mechanism Contributing to Malnutrition and Sarcopenia in Patients with Liver Cirrhosis | HTML](https://www.mdpi.com/ijms/ijms-21-05357/article_deploy/html/images/ijms-21-05357-g001.png)
IJMS | Free Full-Text | Molecular Mechanism Contributing to Malnutrition and Sarcopenia in Patients with Liver Cirrhosis | HTML
![Sugar-based therapy for tuberculosis: Lactulose, a non-absorbable sugar used in the treatment of constipation and hepatic encephalopathy, deacetylates RelA/p65, inhibits inflammatory gene expression downstream of RelA/p65, inhibits TB pathogenesis ... Sugar-based therapy for tuberculosis: Lactulose, a non-absorbable sugar used in the treatment of constipation and hepatic encephalopathy, deacetylates RelA/p65, inhibits inflammatory gene expression downstream of RelA/p65, inhibits TB pathogenesis ...](https://genomediscovery.org/wp-content/uploads/2018/03/Lactulose-4-O-%CE%B2-D-Galactosyl-D-fructose-protects-against-drug-resistant-tuberculosis-through-deacetylation-of-p65.jpg2_.jpg)
Sugar-based therapy for tuberculosis: Lactulose, a non-absorbable sugar used in the treatment of constipation and hepatic encephalopathy, deacetylates RelA/p65, inhibits inflammatory gene expression downstream of RelA/p65, inhibits TB pathogenesis ...
![Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy - Journal of Hepatology Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy - Journal of Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1cd66650-f783-49ca-9fcd-378eebf5f307/gr5.jpg)
Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy - Journal of Hepatology
![Pathophysiology of hepatic encephalopathy and future treatment options | Revista de Gastroenterología de México Pathophysiology of hepatic encephalopathy and future treatment options | Revista de Gastroenterología de México](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S2255534X19300477:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w91RrqeQyRgaVFk/jJir8/OF+9nrJ3gdT+sy7NU1WM0lFlRMIFqUtglIRyG40dNGTvQnuChA+NhdQR+OuPRt5etU4I4Zx495MOYO+eANN1izd4ID7vnKZvES7DfJZPSfEm3a3qRFtd9UPJDEvdj2brJAALzWBXjEY265tgLScKFaroTYD3i5kIHAG81fArSYvAyyfs9UkQ5Tpax2EuAEUUcGKa737CgASJJxxrgLKUC/Nxvu1P+O0pAOZ4b0vo2r9cTe5PqtBwe44k23t2TjuqVg9Rpbl+E46+98kt2sC2L0l)
Pathophysiology of hepatic encephalopathy and future treatment options | Revista de Gastroenterología de México
![Management of Hepatic Encephalopathy in the Neurocritical Care Unit (Chapter 30) - Neurocritical Care Management of Hepatic Encephalopathy in the Neurocritical Care Unit (Chapter 30) - Neurocritical Care](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20190723090755504-0453:9781107587908:06495fig30_5.png?pub-status=live)
Management of Hepatic Encephalopathy in the Neurocritical Care Unit (Chapter 30) - Neurocritical Care
![Frontiers | Disturbance of the Glutamate-Glutamine Cycle, Secondary to Hepatic Damage, Compromises Memory Function | Neuroscience Frontiers | Disturbance of the Glutamate-Glutamine Cycle, Secondary to Hepatic Damage, Compromises Memory Function | Neuroscience](https://www.frontiersin.org/files/MyHome%20Article%20Library/578922/578922_Thumb_400.jpg)